Vacina contra o HPV (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vacina contra o HPV" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

9nih.gov

4^th place

8^th place

6doi.org

2^nd place

4^th place

5who.int

195^th place

150^th place

3handle.net

102^nd place

459^th place

2thelancet.com

2,393^rd place

2,160^th place

1mshpriceguide.org

low place

1web.archive.org

1^st place

1bmj.com

1,226^th place

1,055^th place

1oxfordjournals.org

1,389^th place

585^th place

1aappublications.org

3,763^rd place

2,565^th place

1spsp.org.br

low place

1nytimes.com

7^th place

14^th place

1incthpv.org.br

low place

1medscape.com

719^th place

598^th place

aappublications.org

pediatrics.aappublications.org

Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB. «Sexual-activity related outcomes after human papillomavirus vaccination of 11- to 12-year-olds». Pediatrics 2012;130(5):798-805. Consultado em 16 de agosto de 2015

bmj.com

«Hammad Ali, Basil Donovan, Handan Wand, Tim R H Read, David G Regan, Andrew E Grulich, Christopher K Fairley, Rebecca J Guy. Verrugas genitais em jovens australianos em cinco anos do programa nacional de vacinação contra o papilomavírus humano: dados nacionais de vigilância. BMJ 2013;346:f2032 doi: 10.1136/bmj.f2032. Publicado em 18 de abril de 2013». Consultado em 16 de setembro de 2014

doi.org

dx.doi.org

Kash N, Lee MA, Kollipara R, et al. (abril de 2015). «Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus». Journal of Clinical Medicine. 4 (4): 614–33. PMC 4470159. PMID 26239350. doi:10.3390/jcm4040614
De Vuyst H, Clifford GM, Nascimento MC, et al. (abril de 2009). «Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis». International Journal of Cancer. 124 (7): 1626–36. PMID 19115209. doi:10.1002/ijc.24116
Takes RP, Wierzbicka M, D'Souza G, et al. (dezembro de 2015). «HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?». Oral Oncology. 51 (12): 1057–60. PMID 26520047. doi:10.1016/j.oraloncology.2015.10.011
Thaxton L, Waxman AG (maio de 2015). «Cervical cancer prevention: immunization and screening 2015». The Medical Clinics of North America. 99 (3): 469–77. PMID 25841595. doi:10.1016/j.mcna.2015.01.003
Saville AM (abril de 2016). «Cervical cancer prevention in Australia: Planning for the future». Cancer Cytopathology. 124 (4): 235–40. PMID 26619381. doi:10.1002/cncy.21643
Fesenfeld M, Hutubessy R, Jit M (agosto de 2013). «Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review». Vaccine. 31 (37): 3786–804. PMID 23830973. doi:10.1016/j.vaccine.2013.06.060

handle.net

hdl.handle.net

«Human papillomavirus vaccines: WHO position paper, May 2017» (PDF). Wkly. Epidemiol. Rec. 92 (19): 241–68. 12 de maio de 2017. PMID 28530369. hdl:10665/255353. Resumo divulgativo (PDF)
World Health Organization (maio de 2011). The immunological basis for immunization series: module 19: human papillomavirus infection (PDF). [S.l.]: World Health Organization. ISBN 9789241501590. hdl:10665/44604
World Health Organization (2019). «World Health Organization model list of essential medicines: 21st list 2019». World Health Organization. hdl:10665/325771

incthpv.org.br

Villa, L. «Guia do HPV. Instituto do HPV. Ed. Julho 2013.» (PDF). Consultado em 2 de fevereiro de 2015

medscape.com

emedicine.medscape.com

Gearhart, Peter; et al. «Human Papillomavirus Treatment & Management – Treatment – Approach Considerations. May 26, 2015.». Consultado em 10 de junho de 2015

mshpriceguide.org

«Vaccine, Hpv». International Drug Price Indicator Guide. Consultado em 6 de dezembro de 2015. Cópia arquivada em 6 de outubro de 2017

nih.gov

ncbi.nlm.nih.gov

«Human papillomavirus vaccines: WHO position paper, May 2017» (PDF). Wkly. Epidemiol. Rec. 92 (19): 241–68. 12 de maio de 2017. PMID 28530369. hdl:10665/255353. Resumo divulgativo (PDF)
Kash N, Lee MA, Kollipara R, et al. (abril de 2015). «Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus». Journal of Clinical Medicine. 4 (4): 614–33. PMC 4470159. PMID 26239350. doi:10.3390/jcm4040614
De Vuyst H, Clifford GM, Nascimento MC, et al. (abril de 2009). «Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis». International Journal of Cancer. 124 (7): 1626–36. PMID 19115209. doi:10.1002/ijc.24116
Takes RP, Wierzbicka M, D'Souza G, et al. (dezembro de 2015). «HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?». Oral Oncology. 51 (12): 1057–60. PMID 26520047. doi:10.1016/j.oraloncology.2015.10.011
Thaxton L, Waxman AG (maio de 2015). «Cervical cancer prevention: immunization and screening 2015». The Medical Clinics of North America. 99 (3): 469–77. PMID 25841595. doi:10.1016/j.mcna.2015.01.003
Saville AM (abril de 2016). «Cervical cancer prevention in Australia: Planning for the future». Cancer Cytopathology. 124 (4): 235–40. PMID 26619381. doi:10.1002/cncy.21643
Fesenfeld M, Hutubessy R, Jit M (agosto de 2013). «Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review». Vaccine. 31 (37): 3786–804. PMID 23830973. doi:10.1016/j.vaccine.2013.06.060
Leah M. Smith, MSc, Jay S. Kaufman, PhD, Erin C. Strumpf, PhD, and Linda E. Lévesque, PhD. «Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study.». CMAJ. 2015 Feb 3; 187(2): E74–E81. doi: 10.1503/cmaj.140900
Liddon NC, Leichliter JS, Markowitz LE. «Human papillomavirus vaccine and sexual behavior among adolescent and young women.». Am J Prev Med. 2012 Jan;42(1):44-52

nytimes.com

well.blogs.nytimes.com

ANAHAD O'CONNOR. The New York Times. «HPV Vaccine Doesn't Alter Sexual Behavior, Study Finds». Consultado em 15 de outubro de 2012

oxfordjournals.org

jid.oxfordjournals.org

«Tabrizi SN, Brotherton JM, Kaldor JM, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012;206(11):1645-51. Publicado em 19 de outubro de 2012.». Consultado em 20 de novembro de 2012

spsp.org.br

Sait, MI, Bricks, LF, Hirschheimer, MR. «Vacina quadrivalente contra HPV: o que mais se deve saber?». Consultado em 16 de agosto de 2015

thelancet.com

web.archive.org

«Vaccine, Hpv». International Drug Price Indicator Guide. Consultado em 6 de dezembro de 2015. Cópia arquivada em 6 de outubro de 2017

who.int

«Human papillomavirus vaccines: WHO position paper, May 2017» (PDF). Wkly. Epidemiol. Rec. 92 (19): 241–68. 12 de maio de 2017. PMID 28530369. hdl:10665/255353. Resumo divulgativo (PDF)
«GACVS Safety update on HPV Vaccines.» (PDF). Consultado em 20 de março de 2015
«World Health Organization. Human papillomavirus vaccines: WHO position paper October 2014.» (PDF). Consultado em 20 de março de 2015

apps.who.int

«Human papillomavirus vaccines: WHO position paper, May 2017» (PDF). Wkly. Epidemiol. Rec. 92 (19): 241–68. 12 de maio de 2017. PMID 28530369. hdl:10665/255353. Resumo divulgativo (PDF)
World Health Organization (maio de 2011). The immunological basis for immunization series: module 19: human papillomavirus infection (PDF). [S.l.]: World Health Organization. ISBN 9789241501590. hdl:10665/44604